PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Petroleum ether leaf extract inhibited cell proliferation and induced apoptosis [PMID: 33906326]
Petroleum ether leaf extract induced caspase-dependent apoptosis and cytotoxicity [PMID: 35763625]
Tricaproin isolated from S. glauca inhibited cell growth by targeting Class-1 histone deacetylases [PMID: 29593526]
Hexane extract exhibited potent anticancer activity, with D-erythro-Sphinganine identified as a major constituent [PMID: 41683473]
Bark ethyl acetate fraction induced apoptosis in cancer cells [PMID: 38285785]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33906326 (2021) — The Apoptotic Properties of Leaf Extracts of Simarouba glauca against Human Leukemic Cancer Cells. · Asian Pacific journal of cancer prevention : APJCP
- 2.PMID: 24966429 (2014) — Safety evaluation of Simarouba glauca seed fat. · Journal of food science and technology
- 3.PMID: 33552922 (2021) — Oral acute and sub-chronic toxicity assessment of aqueous leaf extract of Simarouba glauca DC (Paradise tree). · Toxicology reports
- 4.PMID: 35763625 (2022) — Caspase-Dependent Apoptosis Induced by Simarouba Glauca on Human Non-Small-Cell Lung Cancer, A549 Cells. · Asian Pacific journal of cancer prevention : APJCP
- 5.PMID: 41683473 (2026) — Bioactivity-Guided Fractionation, Characterization, and Mechanistic Insights of Anticancer Agents from Simarouba glauca DC. Leaves.